Skip to main content
. Author manuscript; available in PMC: 2016 Feb 2.
Published in final edited form as: Diabetologia. 2013 Apr 19;56(7):1661–1669. doi: 10.1007/s00125-013-2907-z

Fig. 1.

Fig. 1

Inhibiting CX3CR1 results in decreased glomerular volume and FMA in mouse kidneys. (a) Glomerular volume and (b) FMA. (c–f) PAS-stained mouse kidney sections (scale bar, 20 µm): (c) WT non-diabetic mice; (d) Cx3cr1 KO non-diabetic mice; (e) WT diabetic mice; (f) Cx3cr1 KO diabetic mice. Data are mean±SE or images representative of PAS staining in 8–12 mice. *p<0.05 vs control Cx3cr1 WT mice; p<0.05 vs diabetic WT mice. Black bars, control; white bars, diabetes. +/+, WT; −/−, Cx3cr1 KO